Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer

Authors:
Open Access
Publisher website
Google Scholar
Abstract
A significant subset of patients with metastatic breast cancer develops brain metastasis. As efficacy of systemic therapies has improved and patients live longer with metastatic breast cancer, the incidence of breast cancer brain metastases has increased. Brain metastases pose a clinical challenge in diagnosis, treatment, and monitoring across all breast cancer subtypes, and better tools are needed. Liquid biopsy, which enables minimally invasive sampling of a patient’s cancer, has the potential to shed light on intra-cranial tumor biology and to improve patient care by enabling therapy tailoring. Here we review current evidence for the clinical validity of liquid biopsy in patients with breast cancer brain metastases, with a focus on circulating tumor cells and circulating tumor DNA.
Funding Information
  • Conquer Cancer - Israel Cancer Research Fund Career Development Award
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Bonadonna

This publication has 91 references indexed in Scilit: